ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,295Medicare Part D Prescriptions Filled, Including Refills

Rank: 127 out of 1006

$624K Total Retail Price of All Prescriptions

Rank: 139 out of 1006

333 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 333 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

6% of this provider’s 333 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 8,032 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$67 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
PRAVASTATIN SODIUM 363 323 1 15
LISINOPRIL 352 333 2 3
LEVOTHYROXINE SODIUM 348 329 3 2
FUROSEMIDE 210 191 4 6
SIMVASTATIN 207 183 5 1
OMEPRAZOLE 196 155 6 9
METOPROLOL TARTRATE 181 161 7 7
WARFARIN SODIUM 170 138 8 8
AMLODIPINE BESYLATE 169 165 9 4
NAMENDA 146 146 10 34
METOPROLOL SUCCINATE 145 134 11 12
GLIMEPIRIDE 140 139 12 50
ESCITALOPRAM OXALATE 128 106 13 27
TRAMADOL HCL 127 98 14 35
CRESTOR 126 112 15 18
LOVASTATIN 125 110 16 44
NEXIUM 119 85 17 28
METFORMIN HCL ER 119 102 17 56
GABAPENTIN 116 67 19 20
HYDROCHLOROTHIAZIDE 112 106 20 11
ATORVASTATIN CALCIUM 111 109 21 5
POTASSIUM CHLORIDE 107 96 22 30
ATENOLOL 98 86 23 13
TAMSULOSIN HCL 95 92 24 23
PANTOPRAZOLE SODIUM 94 82 25 32
ISOSORBIDE MONONITRATE ER 93 87 26 59
ZETIA 85 70 27 51
CITALOPRAM HBR 84 79 28 24
TRAZODONE HCL 82 81 29 21
MIRTAZAPINE 80 74 30 26
CARBIDOPA-LEVODOPA 76 76 31 80
ALLOPURINOL 74 64 32 31
VYTORIN 71 62 33 145
CARVEDILOL 70 68 34 36
SYMBICORT 69 64 35 147
DOXAZOSIN MESYLATE 68 67 36 87
BENICAR 68 61 36 78
ADVAIR DISKUS 67 67 38 37
ZOLPIDEM TARTRATE 65 30 39 14
SPIRIVA 65 62 39 48
RAMIPRIL 65 53 39 79
LOSARTAN POTASSIUM 59 48 42 22
RANITIDINE HCL 56 41 43 63
DONEPEZIL HCL 55 55 44 17
BUMETANIDE 55 41 44 204
CLOPIDOGREL 54 50 46 46
METFORMIN HCL 52 26 47 10
PLAVIX 51 51 48 61
FLUTICASONE PROPIONATE 50 41 49 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.